Thus, inhibition of the PI3K pathway may result in hyperglycemia due to preventing glucose uptake in skeletal muscle and adipose tissue, increasing gluconeogenesis, and increasing hepatic glycogenolysis, which results in elevated BGLs and a consequent release of insulin (2). The gene discussed is INS; the disease is Hyperglycemia.